methionine has been researched along with ranolazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aldaz, P; Arozarena, I; Attolini, CS; Benitah, SA; Bigas, C; Bocanegra, A; Caballé-Mestres, A; Carrasco-Garcia, E; Chocarro, L; D'Alessandro, A; Dzieciatkowska M, M; Escors, D; Grier, A; Heyn, H; Kochan, G; Larrayoz, IM; Lasheras-Otero, I; Martin, J; Marzo, F; Matheu, A; Moncho-Amor, V; Olias-Arjona, A; Otaegi-Ugartemendia, M; Redondo-Muñoz, M; Rodriguez-Baena, FJ; Sanchez-Laorden, B; Santamaria, E; Urdiroz-Urricelqui, U; Wellbrock, C | 1 |
1 review(s) available for methionine and ranolazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methionine and ranolazine
| Article | Year |
|---|---|
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
Topics: Animals; Immunotherapy; Melanoma; Methionine; Mice; Protein Kinase Inhibitors; Ranolazine; United States | 2023 |